Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
IX Acquisition Corp.IX Acquisition Corp. Reports $2.3 Million Net Loss for Fiscal Year 2024 Amid Merger Plans with AERKOMM Inc.
Accustem Sciences Inc.AccuStem Sciences Reports $1.5 Million Net Loss for Fiscal Year 2024, Focuses on Product Development
CHARLES & COLVARD LTDCharles & Colvard Reports 27% Decline in Net Sales for Fiscal Year Ending June 30, 2024
CONAGRA BRANDS INC.Conagra Brands Reports Decline in Q3 Fiscal 2025 Financial Performance
LIFECORE BIOMEDICAL, INC. \DE\Lifecore Biomedical Reports Decline in Financial Performance for Third Quarter and Nine Months Ended February 23, 2025
NIKE, Inc.NIKE Reports 9% Revenue Decline to $11.3 Billion in Q3 Fiscal 2025
LINDSAY CORPLindsay Corporation Reports 23% Revenue Growth to $187.1 Million in Latest Quarter
CINTAS CORPCintas Corporation Reports 8.4% Revenue Growth to $2.61 Billion for Quarter Ended February 28, 2025
Alchemy Investments Acquisition Corp 1Alchemy Investments Acquisition Corp 1 Reports $4.25M Net Income for Fiscal Year 2024
GPO Plus, Inc.GPO Plus Reports 13% Revenue Growth and Strategic Expansion Initiatives
MSC INDUSTRIAL DIRECT CO INCMSC Industrial Direct Reports Decline in Financial Performance for Recent Quarters
Lamb Weston Holdings, Inc.Lamb Weston Reports Q3 Net Income of $146M, Restructuring Plan Underway
ACUITY INC. (DE)Acuity Inc. Reports 11.1% Net Sales Increase to $1.006 Billion in Q2 Fiscal 2025
Falcon's Beyond Global, Inc.Falcon's Beyond Global Reports $149.5 Million Net Loss for 2024, Revenue Declines to $6.7 Million
BASSETT FURNITURE INDUSTRIES INCBassett Furniture Reports Net Income of $1.854 Million for Quarter Ending March 1, 2025
dMY Squared Technology Group, Inc.dMY Squared Technology Group Reports $819,000 Net Loss and Financial Restatement for Fiscal Year 2024
REVIVA PHARMACEUTICALS HOLDINGS, INC.Reviva Pharmaceuticals Reports $29.9M Net Loss, Advances Brilaroxazine Development
Marblegate Acquisition Corp.Marblegate Acquisition Corp. Reports $2.39 Million Net Loss for Fiscal Year 2024
FIREFLY NEUROSCIENCE, INC.Firefly Neuroscience Reports 76% Revenue Decline and $10.1 Million Operating Loss for Fiscal Year 2024
PDS Biotechnology CorpPDS Biotechnology Reports $37.6 Million Net Loss for 2024, Sees Improvement from Previous Year
Elite Health Systems Inc.Elite Health Systems Reports $2.055 Million Net Loss for Fiscal Year 2024
Tevogen Bio Holdings Inc.Tevogen Bio Reports $13.7 Million Net Loss for 2024, Significant Increase in R&D Expenses
Semnur Pharmaceuticals, Inc.Denali Capital Acquisition Corp. Reports $167K Net Loss and Pursues Merger with Semnur Pharmaceuticals
Stablecoin Development CorpNovaBay Pharmaceuticals Reports Decrease in Sales and Plans Voluntary Dissolution
Bio Green Med Solution, Inc.Cyclacel Pharmaceuticals Reports $11.2 Million Net Loss for Fiscal Year 2024